{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:24:34Z","timestamp":1790083474138,"version":"4.0.1"},"reference-count":271,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.neuroscience.2025.09.027","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T22:09:42Z","timestamp":1758578982000},"page":"163-195","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Early detection of Parkinson\u2019s disease via aptamer-CRISPR platform"],"prefix":"10.1016","volume":"586","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-8037-9576","authenticated-orcid":false,"given":"Kavya","family":"Madhusudhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9406-8179","authenticated-orcid":false,"given":"Aishwarya","family":"Padmanaban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5177-8862","authenticated-orcid":false,"given":"Venkatachalam Deepa","family":"Parvathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2025.09.027_b0005","first-page":"11120","article-title":"Total and Proteinase K-Resistant \u03b1-synuclein levels in erythrocytes, determined by their ability to bind phospholipids","volume":"5","author":"Abd-Elhadi","year":"2015","journal-title":"Associate with Parkinson\u2019s Disease. Sci. Rep."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0010","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1186\/s12951-022-01695-0","article-title":"Ultrasensitive dopamine detection with graphene aptasensor multitransistor arrays","volume":"20","author":"Abrantes","year":"2022","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0015","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41586-020-2279-8","article-title":"Massively multiplexed nucleic acid detection with Cas13","volume":"582","author":"Ackerman","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0020","unstructured":"Alhajj, M., Zubair, M., Farhana, A., 2025. Enzyme Linked Immunosorbent Assay, in: StatPearls. StatPearls Publishing, Treasure Island (FL)."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2020.198129","article-title":"iSCAN: an RT-LAMP-coupled CRISPR-Cas12 module for rapid, sensitive detection of SARS-CoV-2","volume":"288","author":"Ali","year":"2020","journal-title":"Virus Res."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0030","doi-asserted-by":"crossref","first-page":"e867","DOI":"10.1212\/CPJ.0000000000001116","article-title":"CSF and Circulating NfL as Biomarkers for the Discrimination of Parkinson Disease from Atypical Parkinsonian Syndromes: Meta-analysis","volume":"11","author":"Angelopoulou","year":"2021","journal-title":"Neurol. Clin. Pract."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0035","doi-asserted-by":"crossref","first-page":"5921","DOI":"10.1038\/s41467-020-19097-x","article-title":"Streamlined inactivation, amplification, and Cas13-based detection of SARS-CoV-2","volume":"11","author":"Arizti-Sanz","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0040","doi-asserted-by":"crossref","first-page":"12379","DOI":"10.3390\/ijms252212379","article-title":"Parkinson\u2019s Disease: Biomarkers for Diagnosis and Disease Progression","volume":"25","author":"Arya","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2021.113207","article-title":"Rapid and accurate nucleobase detection using FnCas9 and its application in COVID-19 diagnosis","volume":"183","author":"Azhar","year":"2021","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0050","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1177\/0091270011412961","article-title":"Population pharmacokinetics of pegaptanib in patients with neovascular, age-related macular degeneration","volume":"52","author":"Basile","year":"2012","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0055","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(23)01419-8","article-title":"The epidemiology of Parkinson\u2019s disease","volume":"403","author":"Ben-Shlomo","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102296","article-title":"Breaking bad aggregates: how a DNA aptamer cleans up Parkinson\u2019s disease","volume":"35","author":"Berezovski","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0065","unstructured":"Bio Shai Ltd., 2018. PDx Biomarker Assay Study for the Diagnosis of Parkinson's Disease (Clinical trial registration No. NCT02283073). clinicaltrials.gov."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0070","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2311565120","article-title":"In pursuit of degenerative brain disease diagnosis: Dementia biomarkers detected by DNA aptamer-attached portable graphene biosensor","volume":"120","author":"Bodily","year":"2023","journal-title":"PNAS"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0075","article-title":"CRISPR\/Cas13a-Powered Electrochemical Microfluidic Biosensor for Nucleic Acid Amplification-Free miRNA Diagnostics","volume":"31","author":"Bruch","year":"2019","journal-title":"Adv. Mater. Deerfield Beach Fla"},{"issue":"130","key":"10.1016\/j.neuroscience.2025.09.027_b0080","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00702-023-02632-7","article-title":"Blood neurofilament light chain in Parkinson\u2019s disease","volume":"1996","author":"Buhmann","year":"2023","journal-title":"J. Neural Transm. Vienna Austria"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0085","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s11357-020-00192-2","article-title":"A novel multi-marker discovery approach identifies new serum biomarkers for Parkinson\u2019s disease in older people: an EXosomes in PArkiNson Disease (EXPAND) ancillary study","volume":"42","author":"Calvani","year":"2020","journal-title":"GeroScience"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0090","doi-asserted-by":"crossref","first-page":"889","DOI":"10.3389\/fnins.2019.00889","article-title":"Phospho-S129 Alpha-Synuclein is present in Human Plasma but not in Cerebrospinal Fluid as Determined by an Ultrasensitive Immunoassay","volume":"13","author":"Cariulo","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0095","unstructured":"Chahine, L., 2017. Systemic Synuclein Sampling Study (S4) (Clinical trial registration No. NCT02572713). clinicaltrials.gov."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0100","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1538-7836.2008.02932.x","article-title":"A randomized, repeat-dose, pharmacodynamic and safety study of an antidote-controlled factor IXa inhibitor","volume":"6","author":"Chan","year":"2008","journal-title":"J. Thromb. Haemost. JTH"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0105","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41531-024-00664-8","article-title":"Plasma GFAP as a prognostic biomarker of motor subtype in early Parkinson\u2019s disease","volume":"10","author":"Che","year":"2024","journal-title":"NPJ Park. Dis."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0110","article-title":"CRISPR\/Cas12a-based electrochemical biosensor for highly sensitive detection of cTnI","volume":"146","author":"Chen","year":"2022","journal-title":"Bioelectrochemistry Amst. Neth."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0115","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3390\/jfb14020097","article-title":"Towards Point of Care CRISPR-Based Diagnostics: from Method to Device","volume":"14","author":"Chen","year":"2023","journal-title":"J. Funct. Biomater."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0120","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.synbio.2021.07.004","article-title":"Aptamer-based cell-free detection system to detect target protein","volume":"6","author":"Chen","year":"2021","journal-title":"Synth. Syst. Biotechnol."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0125","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.aar6245","article-title":"CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity","volume":"360","author":"Chen","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0130","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1021\/acs.analchem.9b04403","article-title":"CRISPR\/Cas13a Signal Amplification Linked Immunosorbent Assay for Femtomolar Protein Detection","volume":"92","author":"Chen","year":"2020","journal-title":"Anal. Chem."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0135","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.bj.2021.12.010","article-title":"Phosphorylated \u03b1-synuclein in diluted human serum as a biomarker for Parkinson\u2019s disease","volume":"45","author":"Chen","year":"2022","journal-title":"Biomed. J."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2024.116252","article-title":"CRISPR-Cas based diagnostic tools: Bringing diagnosis out of labs","volume":"109","author":"Chhipa","year":"2024","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0145","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/jocd.13081","article-title":"Advances in dermatology using DNA aptamer \u201cAptamin C\u201d innovation: Oxidative stress prevention and effect maximization of vitamin C through antioxidation","volume":"19","author":"Choi","year":"2020","journal-title":"J. Cosmet. Dermatol."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0150","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/ana.25450","article-title":"Magnetic resonance imaging\u2013guided phase 1 trial of putaminal AADC gene therapy for Parkinson\u2019s disease","volume":"85","author":"Christine","year":"2019","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0155","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1161\/CIRCULATIONAHA.109.927756","article-title":"First clinical application of an actively reversible direct factor IXa inhibitor as an anticoagulation strategy in patients undergoing percutaneous coronary intervention","volume":"122","author":"Cohen","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0160","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1212\/CPJ.0000000000000831","article-title":"Genetic Testing for Parkinson Disease","volume":"11","author":"Cook","year":"2021","journal-title":"Neurol. Clin. Pract."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0165","doi-asserted-by":"crossref","first-page":"4823","DOI":"10.3390\/ijms25094823","article-title":"Evaluating the Diagnostic potential of combined Salivary and Skin Biomarkers in Parkinson\u2019s Disease","volume":"25","author":"Costanzo","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0170","doi-asserted-by":"crossref","unstructured":"Cunningham, E.T., Adamis, A.P., Altaweel, M., Aiello, L.P., Bressler, N.M., D\u2019Amico, D.J., Goldbaum, M., Guyer, D.R., Katz, B., Patel, M., Schwartz, S.D., Macugen Diabetic Retinopathy Study Group, 2005. A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema. Ophthalmology 112, 1747\u20131757. DOI: 10.1016\/j.ophtha.2005.06.007.","DOI":"10.1016\/j.ophtha.2005.06.007"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0175","doi-asserted-by":"crossref","first-page":"990","DOI":"10.3390\/metabo13090990","article-title":"Serum-based Lipid Panels for Diagnosis of Idiopathic Parkinson\u2019s Disease","volume":"13","author":"Dahabiyeh","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0180","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1373\/clinchem.2015.245829","article-title":"Recombinase Polymerase Amplification for Diagnostic applications","volume":"62","author":"Daher","year":"2016","journal-title":"Clin. Chem."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0185","doi-asserted-by":"crossref","first-page":"17399","DOI":"10.1002\/anie.201910772","article-title":"Exploring the Trans-Cleavage activity of CRISPR-Cas12a (cpf1) for the Development of a Universal Electrochemical Biosensor","volume":"58","author":"Dai","year":"2019","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0190","doi-asserted-by":"crossref","unstructured":"Dang, U.J., Ziemba, M., Clemens, P.R., Hathout, Y., Conklin, L.S., CINRG Vamorolone 002\/003 Investigators, Hoffman, E.P., 2020. Serum biomarkers associated with baseline clinical severity in young steroid-na\u00efve Duchenne muscular dystrophy boys. Hum. Mol. Genet. 29, 2481\u20132495. DOI: 10.1093\/hmg\/ddaa132.","DOI":"10.1093\/hmg\/ddaa132"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0195","article-title":"A Comprehensive Review of the Role of Biomarkers in Early Diagnosis of Parkinson\u2019s Disease","volume":"16","author":"Das","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0200","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/ana.26550","article-title":"A combined Panel of Salivary Biomarkers in de novo Parkinson\u2019s Disease","volume":"93","author":"De Bartolo","year":"2023","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0205","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.bbi.2023.03.001","article-title":"Hippocampal GFAP-positive astrocyte responses to amyloid and tau pathologies","volume":"110","author":"De Bastiani","year":"2023","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2021.339351","article-title":"A CRISPR\/Cas12a-assisted on-fibre immunosensor for ultrasensitive small protein detection in complex biological samples","volume":"1192","author":"Deng","year":"2022","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0220","doi-asserted-by":"crossref","DOI":"10.1126\/science.abk0637","article-title":"GPNMB confers risk for Parkinson\u2019s disease through interaction with \u03b1-synuclein","volume":"377","author":"Diaz-Ortiz","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0225","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00702-016-1650-2","article-title":"Relationship between the plasma levels of neurodegenerative proteins and motor subtypes of Parkinson\u2019s disease","volume":"124","author":"Ding","year":"2017","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0230","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1212\/WNL.0000000000000316","article-title":"Skin nerve \u03b1-synuclein deposits: a biomarker for idiopathic Parkinson disease","volume":"82","author":"Donadio","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2023.137219","article-title":"Associations of blood UCH-L1 and NfL levels with cognitive dysfunction in Parkinson\u2019s disease patients","volume":"804","author":"Dong","year":"2023","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0240","first-page":"2833","article-title":"Proteomics and bioinformatics approaches for the identification of plasma biomarkers to detect Parkinson\u2019s disease","volume":"18","author":"Dong","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0245","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00401-017-1684-z","article-title":"Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson\u2019s disease","volume":"133","author":"Doppler","year":"2017","journal-title":"Acta Neuropathol. (berl.)"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0250","unstructured":"Duke University, 2019. Blood Biomarker in Early Parkinson's Disease (Clinical trial registration No. NCT03384797). clinicaltrials.gov."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0255","doi-asserted-by":"crossref","DOI":"10.1002\/bies.202000315","article-title":"CRISPR\/Cas technology as a promising weapon to combat viral infections","volume":"43","author":"Escalona-Noguero","year":"2021","journal-title":"Bioessays"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0260","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/mds.26913","article-title":"Biomarker-driven phenotyping in Parkinson disease: a translational missing link in disease-modifying clinical trials","volume":"32","author":"Espay","year":"2017","journal-title":"Mov. Disord. off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0265","unstructured":"Estimation of the 2020 Global Population of Parkinson\u2019s Disease (PD), 2020. . MDS Abstr. URL https:\/\/www.mdsabstracts.org\/abstract\/estimation-of-the-2020-global-population-of-parkinsons-disease-pd\/ (accessed 12.7.24)."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0270","doi-asserted-by":"crossref","unstructured":"Evangelista, B.A., Kim, Y.-S., Kolpashchikov, D.M., 2018. FaptaSyme: a Strategy for Converting a Monomer\/Oligomer Non-Selective to Oligomer-Selective Aptameric Sensors. Chembiochem Eur. J. Chem. Biol. 10.1002\/cbic.201800017. DOI: 10.1002\/cbic.201800017.","DOI":"10.1002\/cbic.201800017"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0275","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0161-6420(03)00085-X","article-title":"Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration: phase II study results","volume":"110","author":"Eyetech Study Group","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0280","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00006982-200204000-00002","article-title":"Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration","volume":"22","author":"Eyetech Study Group","year":"2002","journal-title":"Retina Phila. Pa"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0285","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1038\/s41467-023-38323-w","article-title":"In situ continuous Dopa supply by responsive artificial enzyme for the treatment of Parkinson\u2019s disease","volume":"14","author":"Fang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0290","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3390\/bios14070350","article-title":"Aptamer Screening: Current Methods and Future Trend towards Non-SELEX Approach","volume":"14","author":"Fang","year":"2024","journal-title":"Biosensors"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0295","doi-asserted-by":"crossref","DOI":"10.1002\/chem.202202693","article-title":"Harnessing the CRISPR-Cas13d System for Protein Detection by Dual-Aptamer-based Transcription Amplification","volume":"29","author":"Feng","year":"2023","journal-title":"Chem. \u2013 Eur. J."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0300","unstructured":"Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, 2025. Exploring the Olfactory Mucosa, Blood and Urine for the Identification of Early Biomarkers of Parkinson's Disease, Atypical Parkinsonisms and Neurocognitive Disorders Due to Lewy Body Disease (Clinical trial registration No. NCT06846658). clinicaltrials.gov."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0305","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1038\/srep02540","article-title":"A longitudinal study on \u03b1-synuclein in blood plasma as a biomarker for Parkinson\u2019s disease","volume":"3","author":"Foulds","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0310","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1096\/fj.10-179192","article-title":"Phosphorylated \u03b1-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson\u2019s disease","volume":"25","author":"Foulds","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0315","doi-asserted-by":"crossref","unstructured":"Friberg, T.R., Tolentino, M., LEVEL Study Group, Weber, P., Patel, S., Campbell, S., Goldbaum, M., 2010. Pegaptanib sodium as maintenance therapy in neovascular age-related macular degeneration: the LEVEL study. Br. J. Ophthalmol. 94, 1611\u20131617. DOI: 10.1136\/bjo.2009.174946.","DOI":"10.1136\/bjo.2009.174946"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/acssynbio.2c00496","article-title":"CRISPR-Based Diagnostics: challenges and potential Solutions toward Point-of-Care applications","volume":"12","author":"Ghouneimy","year":"2022","journal-title":"ACS Synth. Biol."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0325","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1161\/CIRCULATIONAHA.107.724864","article-title":"First-in-human evaluation of anti von Willebrand factor therapeutic aptamer ARC1779 in healthy volunteers","volume":"116","author":"Gilbert","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0330","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.1038\/s41467-024-48416-9","article-title":"L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy in newly-diagnosed glioblastoma: dose escalation of the phase I\/II GLORIA trial","volume":"15","author":"Giordano","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioelechem.2025.109038","article-title":"Development of a CRISPR\/Cas13a-based electrochemiluminescence biosensing strategy for sensitive detection of \u03b1-synuclein oligomers in neurodegenerative diseases","volume":"166","author":"Gong","year":"2025","journal-title":"Bioelectrochemistry"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0340","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1136\/bjo.2008.155663","article-title":"Intravitreal injection of pegaptanib sodium for proliferative diabetic retinopathy","volume":"93","author":"Gonz\u00e1lez","year":"2009","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0345","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1126\/science.aaq0179","article-title":"Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6","volume":"360","author":"Gootenberg","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0350","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1126\/science.aam9321","article-title":"Nucleic acid detection with CRISPR-Cas13a\/C2c2","volume":"356","author":"Gootenberg","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0355","doi-asserted-by":"crossref","unstructured":"Gragoudas, E.S., Adamis, A.P., Cunningham, E.T., Feinsod, M., Guyer, D.R., VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group, 2004. Pegaptanib for neovascular age-related macular degeneration. N. Engl. J. Med. 351, 2805\u20132816. DOI: 10.1056\/NEJMoa042760.","DOI":"10.1056\/NEJMoa042760"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0360","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s43856-023-00294-w","article-title":"Quantitative proteomics and phosphoproteomics of urinary extracellular vesicles define putative diagnostic biosignatures for Parkinson\u2019s disease","volume":"3","author":"Hadisurya","year":"2023","journal-title":"Commun. Med."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0365","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41551-019-0371-x","article-title":"Detection of unamplified target genes via CRISPR\u2013Cas9 immobilized on a graphene field-effect transistor","volume":"3","author":"Hajian","year":"2019","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0370","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1038\/s41467-024-48961-3","article-title":"Plasma proteomics identify biomarkers predicting Parkinson\u2019s disease up to 7 years before symptom onset","volume":"15","author":"H\u00e4llqvist","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0375","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.2217\/bmm-2019-0315","article-title":"Levels of Oligomeric \u03b1-Synuclein in Reflex Tears Distinguish Parkinson\u2019S Disease patients from healthy Controls","volume":"13","author":"Hamm-Alvarez","year":"2019","journal-title":"Biomark. Med."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0380","doi-asserted-by":"crossref","first-page":"941","DOI":"10.2217\/bmm-2019-0167","article-title":"Oligomeric \u03b1-Synuclein is increased in Basal Tears of Parkinson\u2019S patients","volume":"13","author":"Hamm-Alvarez","year":"2019","journal-title":"Biomark. Med."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0385","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1212\/WNL.0000000000003680","article-title":"Blood-based NfL","volume":"88","author":"Hansson","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0390","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.amjmed.2019.03.001","article-title":"Parkinson\u2019s Disease and Parkinsonism","volume":"132","author":"Hayes","year":"2019","journal-title":"Am. J. Med."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0395","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2018.00305","article-title":"Recent advances in Biomarkers for Parkinson\u2019s Disease","volume":"10","author":"He","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0400","doi-asserted-by":"crossref","unstructured":"Heimfarth, L., Passos, F.R.S., Monteiro, B.S., Ara\u00fajo, A.A. de S., Quintans J\u00fanior, L.J., Quintans, J. de S.S., 2022. Serum glial fibrillary acidic protein is a body fluid biomarker: A valuable prognostic for neurological disease \u2013 A systematic review. Int. Immunopharmacol. 107, 108624. DOI: 10.1016\/j.intimp.2022.108624.","DOI":"10.1016\/j.intimp.2022.108624"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0405","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1042\/BST20190119","article-title":"Characterization and applications of Type I CRISPR-Cas systems","volume":"48","author":"Hidalgo-Cantabrana","year":"2020","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2025.117855","article-title":"ECL-CRISPR array for multiplexed detection of miRNAs","volume":"289","author":"Hiniduma","year":"2025","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0415","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1021\/acschemneuro.2c00362","article-title":"Inhibition of \u03b1-Synuclein Seeding-Dependent Aggregation by ssDNA Aptamers specific to C-Terminally Truncated \u03b1-Synuclein Fibrils","volume":"13","author":"Hmila","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0420","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1021\/acs.analchem.7b04542","article-title":"Clustered Regularly Interspaced Short Palindromic Repeats\/Cas9 Triggered Isothermal Amplification for Site-specific Nucleic Acid Detection","volume":"90","author":"Huang","year":"2018","journal-title":"Anal. Chem."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0425","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12883-022-02558-9","article-title":"Serum NFL discriminates Parkinson disease from essential tremor and reflect motor and cognition severity","volume":"22","author":"Huang","year":"2022","journal-title":"BMC Neurol."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0430","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/ceo.14001","article-title":"Intravitreous treatment of severe ocular von Hippel\u2013Lindau disease using a combination of the VEGF inhibitor, ranibizumab and PDGF inhibitor, E10030: results from a phase 1\/2 clinical trial","volume":"49","author":"Hwang","year":"2021","journal-title":"Clin. Experiment. Ophthalmol."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0435","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ophtha.2016.10.010","article-title":"Dual Antagonism of PDGF and VEGF in Neovascular Age-Related Macular Degeneration: a phase IIb, Multicenter, Randomized Controlled Trial","volume":"124","author":"Jaffe","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0440","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ophtha.2015.09.004","article-title":"A phase 1 Study of Intravitreous E10030 in Combination with Ranibizumab in Neovascular Age-Related Macular Degeneration","volume":"123","author":"Jaffe","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0445","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ophtha.2020.08.027","article-title":"C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy due to Age-Related Macular Degeneration: a Randomized Pivotal phase 2\/3 Trial","volume":"128","author":"Jaffe","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0450","doi-asserted-by":"crossref","first-page":"8338","DOI":"10.3390\/ijms22158338","article-title":"The Prion-like Spreading of Alpha-Synuclein in Parkinson\u2019s Disease: Update on Models and Hypotheses","volume":"22","author":"Jan","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0455","doi-asserted-by":"crossref","first-page":"832","DOI":"10.3390\/nano10050832","article-title":"\u03b1-Synuclein Oligomer Detection with Aptamer Switch on Reduced Graphene Oxide Electrode","volume":"10","author":"Jang","year":"2020","journal-title":"Nanomaterials"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0460","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1021\/acssensors.3c02167","article-title":"CRISPR-Powered Aptasensor for Diagnostics of Alzheimer\u2019s Disease","volume":"9","author":"Jia","year":"2024","journal-title":"ACS Sens."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0465","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1126\/science.abe7106","article-title":"Noncanonical crRNAs derived from host transcripts enable multiplexable RNA detection by Cas9","volume":"372","author":"Jiao","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0470","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1160\/TH10-01-0027","article-title":"A randomised pilot trial of the anti-von Willebrand factor aptamer ARC1779 in patients with type 2b von Willebrand disease","volume":"104","author":"Jilma","year":"2010","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0475","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1160\/TH11-02-0069","article-title":"A dose ranging phase I\/II trial of the von Willebrand factor inhibiting aptamer ARC1779 in patients with congenital thrombotic thrombocytopenic purpura","volume":"106","author":"Jilma-Stohlawetz","year":"2011","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0480","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1039\/D4AN00595C","article-title":"An electrochemical method based on CRISPR-Cas12a and enzymatic reaction for the highly sensitive detection of tumor marker MUC1 mucin","volume":"149","author":"Jin","year":"2024","journal-title":"Analyst"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0485","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12575-020-00135-3","article-title":"CRISPR-Based Diagnosis of Infectious and Noninfectious Diseases","volume":"22","author":"Jolany Vangah","year":"2020","journal-title":"Biol. Proced. Online"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0490","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1056\/NEJMc2026172","article-title":"Detection of SARS-CoV-2 with SHERLOCK One-Pot Testing","volume":"383","author":"Joung","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0495","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13765-023-00771-9","article-title":"Aptamer-based CRISPR-Cas powered diagnostics of diverse biomarkers and small molecule targets","volume":"66","author":"Kadam","year":"2023","journal-title":"Appl. Biol. Chem."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0500","first-page":"643","article-title":"CRISPR-based diagnostics. Nat","volume":"5","author":"Kaminski","year":"2021","journal-title":"Biomed. Eng."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0505","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.RA120.014553","article-title":"Revisiting T7 RNA polymerase transcription in vitro with the Broccoli RNA aptamer as a simplified real-time fluorescent reporter","volume":"296","author":"Kartje","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0510","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1038\/s41596-019-0210-2","article-title":"SHERLOCK: nucleic acid detection with CRISPR nucleases","volume":"14","author":"Kellner","year":"2019","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0515","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.3390\/cells12091309","article-title":"GFAP as a potential Biomarker for Alzheimer\u2019s Disease: a Systematic Review and Meta-Analysis","volume":"12","author":"Kim","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0520","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.3390\/biom11081162","article-title":"CRISPR as a Diagnostic Tool","volume":"11","author":"Kim","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0525","doi-asserted-by":"crossref","unstructured":"Kishore, A., Sturm, M., Soman Pillai, K., Hakkaart, C., Kalikavil Puthanveedu, D., Urulangodi, M., Krishnan, S., Ashok Kumar Sreelatha, A., Rajan, R., Pal, P.K., Yadav, R., Sarma, G., Casadei, N., Gasser, T., Bauer, P., Riess, O., Sharma, M., 2024. Resequencing the complete SNCA locus in Indian patients with Parkinson\u2019s disease. Npj Park. Dis. 10, 1\u20135. DOI: 10.1038\/s41531-024-00676-4.","DOI":"10.1038\/s41531-024-00676-4"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0530","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41531-021-00239-x","article-title":"A six-metabolite panel as potential blood-based biomarkers for Parkinson\u2019s disease","volume":"7","author":"Klatt","year":"2021","journal-title":"NPJ Park. Dis."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0535","doi-asserted-by":"crossref","first-page":"393","DOI":"10.7861\/clinmed.2020-0220","article-title":"Update on the diagnosis and management of Parkinson\u2019s disease","volume":"20","author":"Kobylecki","year":"2020","journal-title":"Clin. Med."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0540","article-title":"Point-of-care CRISPR-based Diagnostics with Premixed and Freeze-dried Reagents","volume":"66703","author":"Kongkaew","year":"2024","journal-title":"J. vis. Exp."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0545","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.mib.2017.05.008","article-title":"Diversity, classification and evolution of CRISPR-Cas systems","volume":"37","author":"Koonin","year":"2017","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0550","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.3324\/haematol.2021.279948","article-title":"The von Willebrand factor A-1 domain binding aptamer BT200 elevates plasma levels of von Willebrand factor and factor VIII: a first-in-human trial","volume":"107","author":"Kovacevic","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0555","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1038\/s41467-019-09985-2","article-title":"Controlling CRISPR-Cas9 with ligand-activated and ligand-deactivated sgRNAs","volume":"10","author":"Kundert","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0560","article-title":"Progression of Nonmotor Symptoms in Parkinson\u2019s Disease by sex and Motor Laterality","volume":"2021","author":"Kurlawala","year":"2021","journal-title":"Park. Dis."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105962","article-title":"Diagnostic metabolomic profiling of Parkinson\u2019s disease biospecimens","volume":"177","author":"LeWitt","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0570","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.snb.2018.08.024","article-title":"Gold Nanoparticle-DNA conjugates enhanced determination of dopamine by aptamer-based microcantilever array sensor","volume":"275","author":"Li","year":"2018","journal-title":"Sens. Actuators B Chem."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0575","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1002\/med.21718","article-title":"Progress in the molecular pathogenesis and nucleic acid therapeutics for Parkinson\u2019s disease in the precision medicine era","volume":"40","author":"Li","year":"2020","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2020.121670","article-title":"Aptamer-based CRISPR\/Cas12a assay for the ultrasensitive detection of extracellular vesicle proteins","volume":"221","author":"Li","year":"2021","journal-title":"Talanta"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0585","article-title":"A Panel of Plasma Biomarkers for Differential Diagnosis of Parkinsonian Syndromes","volume":"16","author":"Li","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0590","doi-asserted-by":"crossref","first-page":"19874","DOI":"10.1021\/jacs.4c03061","article-title":"Proteome Fishing for CRISPR\/Cas12a-based Orthogonal Multiplex Aptamer Sensing","volume":"146","author":"Li","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0595","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/s41422-018-0022-x","article-title":"CRISPR-Cas12a has both cis- and trans-cleavage activities on single-stranded DNA","volume":"28","author":"Li","year":"2018","journal-title":"Cell Res."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0600","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.623977","article-title":"Alterations of Erythrocytic Phosphorylated Alpha-Synuclein in Different Subtypes and Stages of Parkinson\u2019s Disease","volume":"13","author":"Li","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2023.137394","article-title":"Association between serum neurofilament light chain levels and sleep disorders in patients with Parkinson\u2019s disease","volume":"812","author":"Li","year":"2023","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0610","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1007\/s11357-022-00576-6","article-title":"Elevated \u03b1-synuclein and NfL levels in tear fluids and decreased retinal microvascular densities in patients with Parkinson\u2019s disease","volume":"44","author":"Lin","year":"2022","journal-title":"GeroScience"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0615","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0140-6736(15)00515-2","article-title":"Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial","volume":"387","author":"Lincoff","year":"2016","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0620","doi-asserted-by":"crossref","first-page":"780","DOI":"10.3390\/bios12100780","article-title":"Detection of Alpha-Fetoprotein using Aptamer-based Sensors","volume":"12","author":"Liu","year":"2022","journal-title":"Biosensors"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0625","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1039\/D2AN00697A","article-title":"A functionalized magnetic nanoparticle regulated CRISPR-Cas12a sensor for the ultrasensitive detection of alpha-fetoprotein","volume":"147","author":"Liu","year":"2022","journal-title":"Analyst"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0630","article-title":"Neurofilament light as a biomarker for motor decline in Parkinson\u2019s disease","volume":"16","author":"Liu","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0635","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/brain\/awab306","article-title":"Imaging protein aggregates in the serum and cerebrospinal fluid in Parkinson\u2019s disease","volume":"145","author":"Lobanova","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0640","doi-asserted-by":"crossref","first-page":"11301","DOI":"10.1007\/s11033-022-07752-z","article-title":"The CRISPR-Cas system as a tool for diagnosing and treating infectious diseases","volume":"49","author":"Lou","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0645","doi-asserted-by":"crossref","first-page":"6575","DOI":"10.1093\/nar\/gkac458","article-title":"An in-library ligation strategy and its application in CRISPR\/Cas9 screening of high-order gRNA combinations","volume":"50","author":"Lu","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0650","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.ophtha.2007.02.021","article-title":"Pegaptanib 1-year systemic safety results from a safety-pharmacokinetic trial in patients with neovascular age-related macular degeneration","volume":"114","author":"Macugen AMD Study Group","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0655","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1136\/jnnp-2014-309562","article-title":"A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes","volume":"86","author":"Magdalinou","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0660","first-page":"681","article-title":"The Concept of Prodromal Parkinson\u2019s Disease","volume":"5","author":"Mahlknecht","year":"2015","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0665","doi-asserted-by":"crossref","first-page":"9726","DOI":"10.1021\/bi9700633","article-title":"In vitro selection of dopamine RNA ligands","volume":"36","author":"Mannironi","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0670","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1161\/STROKEAHA.111.616649","article-title":"The von Willebrand inhibitor ARC1779 reduces cerebral embolization after carotid endarterectomy: a randomized trial","volume":"42","author":"Markus","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0675","doi-asserted-by":"crossref","first-page":"e1479","DOI":"10.1212\/WNL.0000000000007179","article-title":"Serum NFL discriminates Parkinson disease from atypical parkinsonisms","volume":"92","author":"Marques","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0680","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/B978-0-323-85538-9.00014-6","article-title":"Challenges in the study of individuals at risk for Parkinson disease","volume":"192","author":"Marras","year":"2023","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0685","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1021\/acssensors.3c00757","article-title":"Non-invasive monitoring of \u03b1-Synuclein in Saliva for Parkinson\u2019s Disease using Organic Electrolyte-Gated FET Aptasensor","volume":"8","author":"Massey","year":"2023","journal-title":"ACS Sens."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0690","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.msard.2018.11.032","article-title":"Cerebrospinal fluid biomarkers link toxic astrogliosis and microglial activation to multiple sclerosis severity","volume":"28","author":"Masvekar","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0695","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102251","article-title":"Selection of DNA aptamers that prevent the fibrillization of \u03b1-synuclein protein in cellular and mouse models","volume":"35","author":"McConnell","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0700","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jclinepi.2006.09.001","article-title":"A randomized trial of Pegaptanib sodium for age-related macular degeneration used an innovative design to explore disease-modifying effects","volume":"60","author":"Mills","year":"2007","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0705","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.3390\/cells10113109","article-title":"Heat Shock-Related Protein responses and Inflammatory Protein changes are Associated with Mild Prolonged Hypoglycemia","volume":"10","author":"Moin","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0710","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1002\/mds.28206","article-title":"Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson\u2019s Disease Progression","volume":"35","author":"Mollenhauer","year":"2020","journal-title":"Mov. Disord. off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0715","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/ane.13700","article-title":"Blood based biomarkers for movement disorders","volume":"146","author":"Morris","year":"2022","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0720","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","article-title":"The pathogenesis of Parkinson\u2019s disease","volume":"403","author":"Morris","year":"2024","journal-title":"The Lancet"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0725","first-page":"198","article-title":"CRISPR-Based Diagnostics for Point-of-Care Viral Detection","volume":"2","author":"Mosa","year":"2022","journal-title":"Int. J. Transl. Med."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0730","doi-asserted-by":"crossref","first-page":"6811","DOI":"10.1093\/nar\/gkaa477","article-title":"5\u2032 modifications to CRISPR\u2013Cas9 gRNA can change the dynamics and size of R-loops and inhibit DNA cleavage","volume":"48","author":"Mullally","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0735","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1126\/science.aas8836","article-title":"Field-deployable viral diagnostics using CRISPR-Cas13","volume":"360","author":"Myhrvold","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0740","first-page":"187","article-title":"Aptamer-based Proteomic Signature of Intensive phase Treatment Response in Pulmonary Tuberculosis","volume":"94","author":"Nahid","year":"2014","journal-title":"Tuberc. Edinb. Scotl."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0745","first-page":"981","article-title":"Detection and Assessment of \u03b1-Synuclein Oligomers in the Urine of Parkinson\u2019s Disease patients","volume":"10","author":"Nam","year":"2020","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0750","doi-asserted-by":"crossref","first-page":"13173","DOI":"10.3390\/ijerph182413173","article-title":"Testing Antigens, Antibodies, and Immune Cells in COVID-19 as a Public Health Topic\u2014Experience and Outlines","volume":"18","author":"Neagu","year":"2021","journal-title":"Int. J. Environ. Res. Public. Health"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0755","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2024.105760","article-title":"The misfolding mystery: \u03b1-synuclein and the pathogenesis of Parkinson\u2019s disease","volume":"177","author":"Negi","year":"2024","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0760","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1039\/D1PY00516B","article-title":"Chemical conjugation of nucleic acid aptamers and synthetic polymers","volume":"12","author":"Nerantzaki","year":"2021","journal-title":"Polym. Chem."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0765","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1007\/s00415-023-12117-y","article-title":"Relationship between plasma NFL and disease progression in Parkinson\u2019s disease: a prospective cohort study","volume":"271","author":"Ou","year":"2024","journal-title":"J. Neurol."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0770","first-page":"S176","article-title":"Improving outcomes through early diagnosis of Parkinson\u2019s disease","volume":"18","author":"Pagan","year":"2012","journal-title":"Am. J. Manag. Care"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0775","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.parkreldis.2022.05.020","article-title":"Dissociable contribution of plasma NfL and p-tau181 to cognitive impairment in Parkinson\u2019s disease","volume":"105","author":"Pagonabarraga","year":"2022","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0780","first-page":"S94","article-title":"Early diagnosis of Parkinson\u2019s disease: recommendations from diagnostic clinical guidelines","volume":"16 Suppl Implications","author":"Pahwa","year":"2010","journal-title":"Am. J. Manag. Care"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0785","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.cell.2016.04.059","article-title":"Rapid, Low-cost Detection of Zika Virus using Programmable Biomolecular Components","volume":"165","author":"Pardee","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0790","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1474-4422(19)30024-9","article-title":"CSF and blood biomarkers for Parkinson\u2019s disease","volume":"18","author":"Parnetti","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0795","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40035-023-00374-w","article-title":"Large-scale proximity extension assay reveals CSF midkine and DOPA decarboxylase as supportive diagnostic biomarkers for Parkinson\u2019s disease","volume":"12","author":"Paslawski","year":"2023","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0800","article-title":"Aptamer Proteomics for Biomarker Discovery in Heart failure with Preserved Ejection Fraction: the PARAGON\u2010HF Proteomic Substudy. J. Am. Heart Assoc. Cardiovasc","volume":"13","author":"Patel-Murray","year":"2024","journal-title":"Cerebrovasc. Dis."},{"issue":"85","key":"10.1016\/j.neuroscience.2025.09.027_b0805","first-page":"1","article-title":"Parkinson\u2019s, where are we heading?","volume":"2005","author":"Pavese","year":"2024","journal-title":"Br. J. Hosp. Med. Lond. Engl."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0810","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200132","article-title":"Inflammatory Biomarkers in newly Diagnosed patients with Parkinson Disease and Related Neurodegenerative Disorders","volume":"10","author":"Pedersen","year":"2023","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0815","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1089\/crispr.2022.0052","article-title":"RNA-Responsive gRNAs for Controlling CRISPR activity: current advances, Future Directions, and potential applications","volume":"5","author":"Pelea","year":"2022","journal-title":"CRISPR J."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0820","doi-asserted-by":"crossref","DOI":"10.1016\/j.snb.2020.128164","article-title":"CRISPR-Cas12a based aptasensor for sensitive and selective ATP detection","volume":"320","author":"Peng","year":"2020","journal-title":"Sens. Actuators B Chem."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0825","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/s41433-023-02848-7","article-title":"Clinical proof of concept for anti-FGF2 therapy in exudative age-related macular degeneration (nAMD): phase 2 trials in treatment-na\u00efve and anti-VEGF pretreated patients","volume":"38","author":"Pereira","year":"2024","journal-title":"Eye"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0830","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/s43587-023-00478-y","article-title":"DOPA decarboxylase is an emerging biomarker for Parkinsonian disorders including preclinical Lewy body disease","volume":"3","author":"Pereira","year":"2023","journal-title":"Nat. Aging"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0835","doi-asserted-by":"crossref","first-page":"7537","DOI":"10.1007\/s00415-024-12669-7","article-title":"Plasma NfL, GFAP, amyloid, and p-tau species as Prognostic biomarkers in Parkinson\u2019s disease","volume":"271","author":"Pilotto","year":"2024","journal-title":"J. Neurol."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0840","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.parkreldis.2021.04.016","article-title":"Plasma NfL, clinical subtypes and motor progression in Parkinson\u2019s disease","volume":"87","author":"Pilotto","year":"2021","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0845","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1093\/nar\/gkz1197","article-title":"Type IV CRISPR\u2013Cas systems are highly diverse and involved in competition between plasmids","volume":"48","author":"Pinilla-Redondo","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0850","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11239-011-0588-3","article-title":"Dose selection for a direct and selective factor IXa inhibitor and its complementary reversal agent: translating pharmacokinetic and pharmacodynamic properties of the REG1 system to clinical trial design","volume":"32","author":"Povsic","year":"2011","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0855","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1093\/eurheartj\/ehr179","article-title":"Pegnivacogin results in near complete FIX inhibition in acute coronary syndrome patients: RADAR pharmacokinetic and pharmacodynamic substudy","volume":"32","author":"Povsic","year":"2011","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0860","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.3390\/ijms23031757","article-title":"CRISPR Approaches for the Diagnosis of Human Diseases","volume":"23","author":"Puig-Serra","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0865","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2023.341998","article-title":"Highly sensitive detection of Salmonella based on dual-functional HCR-mediated multivalent aptamer and amplification-free CRISPR\/Cas12a system","volume":"1284","author":"Qiao","year":"2023","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0870","doi-asserted-by":"crossref","DOI":"10.1016\/j.snb.2021.130713","article-title":"CRISPR\/Cas12a-regulated homogeneous electrochemical aptasensor for amplified detection of protein","volume":"348","author":"Qing","year":"2021","journal-title":"Sens. Actuators B Chem."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0875","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1021\/acssynbio.7b00446","article-title":"Highly Effective and Low-cost MicroRNA Detection with CRISPR-Cas9","volume":"7","author":"Qiu","year":"2018","journal-title":"ACS Synth. Biol."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0880","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1093\/nar\/gkz418","article-title":"FLASH: a next-generation CRISPR diagnostic for multiplexed detection of antimicrobial resistance sequences","volume":"47","author":"Quan","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0885","doi-asserted-by":"crossref","first-page":"24","DOI":"10.37349\/ent.2023.00036","article-title":"Pathophysiology of non-motor signs in Parkinsons disease: some recent updating with brief presentation","volume":"3","author":"Radad","year":"2023","journal-title":"Explor. Neuroprotective Ther."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0890","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3389\/fneur.2020.00524","article-title":"Genetic Architecture of Parkinson\u2019s Disease in the Indian Population: Harnessing Genetic Diversity to Address critical Gaps in Parkinson\u2019s Disease Research","volume":"11","author":"Rajan","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0895","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jns.2012.08.029","article-title":"Challenges in diagnosis of young onset Parkinson\u2019s disease","volume":"323","author":"Rana","year":"2012","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0900","doi-asserted-by":"crossref","unstructured":"Rauch, J.N., Valois, E., Solley, S.C., Braig, F., Lach, R.S., Audouard, M., Ponce-Rojas, J.C., Costello, M.S., Baxter, N.J., Kosik, K.S., Arias, C., Acosta-Alvear, D., Wilson, M.Z., 2021. A Scalable, Easy-to-Deploy Protocol for Cas13-Based Detection of SARS-CoV-2 Genetic Material. J. Clin. Microbiol. 59, e02402-20. DOI: 10.1128\/JCM.02402-20.","DOI":"10.1128\/JCM.02402-20"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0905","doi-asserted-by":"crossref","unstructured":"Rees, R.N., Acharya, A.P., Schrag, A., Noyce, A.J., 2018. An early diagnosis is not the same as a timely diagnosis of Parkinson\u2019s disease. F1000Research 7, F1000 Faculty Rev-1106. DOI: 10.12688\/f1000research.14528.1.","DOI":"10.12688\/f1000research.14528.1"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0910","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/jnc.15601","article-title":"Plasma \u03b1-synuclein and phosphorylated tau 181 as a diagnostic biomarker panel for de novo Parkinson\u2019s disease","volume":"161","author":"Ren","year":"2022","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0915","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.omtn.2019.07.008","article-title":"Exosomal DNA Aptamer Targeting \u03b1-Synuclein Aggregates Reduced Neuropathological Deficits in a Mouse Parkinson\u2019s Disease Model","volume":"17","author":"Ren","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0920","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/IAE.0b013e318261a73c","article-title":"Intravitreal pegaptanib sodium (Macugen) for treatment of myopic choroidal neovascularization: a morphologic and functional study","volume":"33","author":"Rinaldi","year":"2013","journal-title":"Retina Phila. Pa"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0925","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1503\/cmaj.151179","article-title":"An update on the diagnosis and treatment of Parkinson disease. CMAJ can","volume":"188","author":"Rizek","year":"2016","journal-title":"Med. Assoc. J. J. Assoc. Medicale Can."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0930","doi-asserted-by":"crossref","first-page":"5","DOI":"10.31083\/j.jin2101005","article-title":"Development and validation of anti-human Alpha synuclein DNA aptamer using computer modelling techniques-an in silico study","volume":"21","author":"Rock","year":"2022","journal-title":"J. Integr. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0935","unstructured":"Rodriguez-Leyva, I., 2021. Usefulness of \u03b1-synuclein as a Marker for Early Diagnosis of Parkinson's Disease in Skin Biopsy. (Clinical trial registration No. NCT01380899). clinicaltrials.gov."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0940","series-title":"RNA Nanostructures: Design, Characterization, and Applications","first-page":"277","article-title":"Aptamer Conjugated RNA\/DNA Hybrid Nanostructures Designed for Efficient Regulation of Blood Coagulation","author":"Rolband","year":"2023"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0945","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s10637-013-0045-6","article-title":"A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma","volume":"32","author":"Rosenberg","year":"2014","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0950","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.3390\/molecules27031114","article-title":"An Update of Nucleic Acids Aptamers Theranostic Integration with CRISPR\/Cas Technology","volume":"27","author":"Roueinfar","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0955","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s00401-024-02706-0","article-title":"Comprehensive proteomics of CSF, plasma, and urine identify DDC and other biomarkers of early Parkinson\u2019s disease","volume":"147","author":"Rutledge","year":"2024","journal-title":"Acta Neuropathol. (berl.)"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0960","doi-asserted-by":"crossref","unstructured":"Sabaei, M., Rahimian, S., Haj Mohamad Ebrahim Ketabforoush, A., Rasoolijazi, H., Zamani, B., Hajiakhoundi, F., Soleimani, M., Shahidi, G., Faramarzi, M., 2023. Salivary levels of disease-related biomarkers in the early stages of Parkinson\u2019s and Alzheimer\u2019s disease: A cross-sectional study. IBRO Neurosci. Rep. 14, 285\u2013292. DOI: 10.1016\/j.ibneur.2023.03.004.","DOI":"10.1016\/j.ibneur.2023.03.004"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0965","doi-asserted-by":"crossref","unstructured":"Sabnam, S., Kumar, R., Pranav, 2025. Biofunctionalized nanomaterials for Parkinson\u2019s disease theranostics: potential for efficient PD biomarker detection and effective therapy. Biomater. Sci. DOI: 10.1039\/D5BM00179J.","DOI":"10.1039\/D5BM00179J"},{"key":"10.1016\/j.neuroscience.2025.09.027_b0970","first-page":"2937","article-title":"A FRET-based aptasensor for the detection of \u03b1-synuclein oligomers as biomarkers of Parkinson\u2019s disease","volume":"14","author":"Saedi","year":"2022","journal-title":"Anal. Methods Adv. Methods Appl."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0975","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1002\/alz.13560","article-title":"Association of plasma biomarkers with cognition, cognitive decline, and daily function across and within neurodegenerative diseases: results from the Ontario Neurodegenerative Disease Research Initiative","volume":"20","author":"Sanchez","year":"2023","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0980","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1017\/qrd.2022.7","article-title":"Inconsistent treatments of the kinetics of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) impair assessment of its diagnostic potential","volume":"3","author":"Santiago","year":"2022","journal-title":"QRB Discov."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0985","unstructured":"Schiess, M., 2011. Cross-Sectional Cohort Study of Laboratory and Clinical Patterns in Early PD (Clinical trial registration No. NCT00817453). clinicaltrials.gov."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0990","doi-asserted-by":"crossref","first-page":"958","DOI":"10.3109\/02713683.2011.597536","article-title":"Comparing treatment of neovascular age-related macular degeneration with sequential intravitreal Avastin and Macugen versus intravitreal mono-therapy\u2013a pilot study","volume":"36","author":"Schmid-Kubista","year":"2011","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.neuroscience.2025.09.027_b0995","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1002\/mds.28738","article-title":"Systematic Assessment of 10 Biomarker Candidates focusing on \u03b1-Synuclein-Related Disorders","volume":"36","author":"Schulz","year":"2021","journal-title":"Mov. Disord. off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1000","doi-asserted-by":"crossref","unstructured":"Scriba, T.J., Penn-Nicholson, A., Shankar, S., Hraha, T., Thompson, E.G., Sterling, D., Nemes, E., Darboe, F., Suliman, S., Amon, L.M., Mahomed, H., Erasmus, M., Whatney, W., Johnson, J.L., Boom, W.H., Hatherill, M., Valvo, J., De Groote, M.A., Ochsner, U.A., Aderem, A., Hanekom, W.A., Zak, D.E., other members of the ACS cohort study team, 2017. Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis disease. PLoS Pathog. 13, e1006687. DOI: 10.1371\/journal.ppat.1006687.","DOI":"10.1371\/journal.ppat.1006687"},{"key":"10.1016\/j.neuroscience.2025.09.027_b1005","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s44385-024-00005-7","article-title":"Exploring dopa decarboxylase as an ideal biomarker in Parkinson\u2019s disease with focus on regulatory mechanisms, cofactor influences, and metabolic implications","volume":"2","author":"Shebl","year":"2025","journal-title":"Npj Biomed. Innov."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1010","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2024.126267","article-title":"An ultra-sensitive CRISPR-Cas12a and aptamer-based biosensor utilizing Entropy-driven catalytic DNA networks for precise detection of DNA Methyltransferase 1","volume":"276","author":"Shen","year":"2024","journal-title":"Talanta"},{"key":"10.1016\/j.neuroscience.2025.09.027_b1015","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41467-019-14135-9","article-title":"Sensitive detection of a bacterial pathogen using allosteric probe-initiated catalysis and CRISPR-Cas13a amplification reaction","volume":"11","author":"Shen","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1020","doi-asserted-by":"crossref","DOI":"10.1093\/jambio\/lxad035","article-title":"Progress and bioapplication of CRISPR-based one-step, quantitative and multiplexed infectious disease diagnostics","volume":"134","author":"Shen","year":"2023","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1025","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1002\/jmv.26889","article-title":"Development and application of sensitive, specific, and rapid CRISPR\u2010Cas13\u2010based diagnosis","volume":"93","author":"Shihong Gao","year":"2021","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1030","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1002\/jmv.26889","article-title":"Development and application of sensitive, specific, and rapid CRISPR-Cas13-based diagnosis","volume":"93","author":"Shihong Gao","year":"2021","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1035","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1186\/s12859-023-05577-6","article-title":"AptaTrans: a deep neural network for predicting aptamer-protein interaction using pretrained encoders","volume":"24","author":"Shin","year":"2023","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.neuroscience.2025.09.027_b1040","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.molcel.2015.10.008","article-title":"Discovery and Functional Characterization of Diverse Class 2 CRISPR-Cas Systems","volume":"60","author":"Shmakov","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.neuroscience.2025.09.027_b1045","doi-asserted-by":"crossref","unstructured":"Sitron, C.S., Trinkaus, V.A., Galesic, A., Garhammer, M., Yuste Checa, P., Dransfeld, U., Feigenbutz, D., Zhang, J., Dudanova, I., Harper, J.W., Hartl, F.U., 2025. \u03b1-Synuclein aggregates inhibit ESCRT-III through sequestration and collateral degradation. DOI: 10.1101\/2025.01.13.632710.","DOI":"10.1101\/2025.01.13.632710"},{"key":"10.1016\/j.neuroscience.2025.09.027_b1050","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3390\/bios14100460","article-title":"Harnessing CRISPR\/Cas Systems for DNA and RNA Detection: Principles, Techniques, and challenges","volume":"14","author":"Son","year":"2024","journal-title":"Biosensors"},{"key":"10.1016\/j.neuroscience.2025.09.027_b1055","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.135425","article-title":"Neuroprotective effect of NXP031 in the MPTP-induced Parkinson\u2019s disease model","volume":"740","author":"Song","year":"2021","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1060","doi-asserted-by":"crossref","DOI":"10.7754\/Clin.Lab.2020.200852","article-title":"Lower Plasma \u03b1-Synuclein Levels are Associated with Cognitive Impairment in Parkinson\u2019s Disease","volume":"67","author":"Song","year":"2021","journal-title":"Clin. Lab."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1065","doi-asserted-by":"crossref","unstructured":"Sultan, M.B., Zhou, D., Loftus, J., Dombi, T., Ice, K.S., Macugen 1013 Study Group, 2011. A phase 2\/3, multicenter, randomized, double-masked, 2-year trial of pegaptanib sodium for the treatment of diabetic macular edema. Ophthalmology 118, 1107\u20131118. DOI: 10.1016\/j.ophtha.2011.02.045.","DOI":"10.1016\/j.ophtha.2011.02.045"},{"key":"10.1016\/j.neuroscience.2025.09.027_b1070","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.snb.2017.01.171","article-title":"Aptasensors for the selective detection of alpha-synuclein oligomer by colorimetry, surface plasmon resonance and electrochemical impedance spectroscopy","volume":"245","author":"Sun","year":"2017","journal-title":"Sens. Actuators B Chem."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1075","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41531-023-00447-7","article-title":"Plasma GFAP in Parkinson\u2019s disease with cognitive impairment and its potential to predict conversion to dementia","volume":"9","author":"Tang","year":"2023","journal-title":"NPJ Park. Dis."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217273","article-title":"The prediction of early preeclampsia: results from a longitudinal proteomics study","volume":"14","author":"Tarca","year":"2019","journal-title":"PloS One"},{"key":"10.1016\/j.neuroscience.2025.09.027_b1085","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s13059-019-1742-z","article-title":"CDetection: CRISPR-Cas12b-based DNA detection with sub-attomolar sensitivity and single-base specificity","volume":"20","author":"Teng","year":"2019","journal-title":"Genome Biol."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1090","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00216-024-05663-5","article-title":"SERS-based CRISPR\/Cas12a assays for protein biomarker prostate-specific antigen detection","volume":"417","author":"Teng","year":"2025","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1095","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.molcel.2018.09.018","article-title":"CRISPR-Based Technologies: Impact of RNA-Targeting Systems","volume":"72","author":"Terns","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.neuroscience.2025.09.027_b1100","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2021.153443","article-title":"Recent advances and challenges of RT-PCR tests for the diagnosis of COVID-19","volume":"221","author":"Teymouri","year":"2021","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1105","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40035-019-0155-y","article-title":"Erythrocytic \u03b1-Synuclein as a potential biomarker for Parkinson\u2019s disease","volume":"8","author":"Tian","year":"2019","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1110","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","article-title":"Challenges in the diagnosis of Parkinson\u2019s disease","volume":"20","author":"Tolosa","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1115","doi-asserted-by":"crossref","first-page":"5542","DOI":"10.1021\/ac300330g","article-title":"Selection of DNA aptamers that recognize \u03b1-synuclein oligomers using a competitive screening method","volume":"84","author":"Tsukakoshi","year":"2012","journal-title":"Anal. Chem."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1120","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s10529-010-0200-5","article-title":"Screening of DNA aptamer which binds to alpha-synuclein","volume":"32","author":"Tsukakoshi","year":"2010","journal-title":"Biotechnol. Lett."},{"issue":"124","key":"10.1016\/j.neuroscience.2025.09.027_b1125","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","article-title":"Epidemiology of Parkinson\u2019s disease","volume":"1996","author":"Tysnes","year":"2017","journal-title":"J. Neural Transm. Vienna Austria"},{"key":"10.1016\/j.neuroscience.2025.09.027_b1130","unstructured":"University Hospital, Grenoble, 2024. Evaluation De La Performance Clinique D'un Nouveau Biomarqueur Sanguin Des Phases Pr\u00e9coces De La Maladie De Parkinson (Clinical trial registration No. NCT05385315). clinicaltrials.gov."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1135","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106237","article-title":"Neurofilament light predicts worse nonmotor symptoms and depression in Parkinson\u2019s disease","volume":"185","author":"Urso","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1140","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpc.2024.107308","article-title":"In silico analysis of aptamer-RNA conjugate interactions with human transferrin receptor","volume":"314","author":"Vasconcelos","year":"2024","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1145","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1111\/j.1538-7836.2012.04742.x","article-title":"A phase 1 ascending dose study of a subcutaneously administered factor IXa inhibitor and its active control agent","volume":"10","author":"Vavalle","year":"2012","journal-title":"J. Thromb. Haemost. JTH"},{"key":"10.1016\/j.neuroscience.2025.09.027_b1150","doi-asserted-by":"crossref","unstructured":"VEGF Inhibition Study in Ocular Neovascularization (V.I.S.I.O.N.) Clinical Trial Group, D\u2019Amico, D.J., Masonson, H.N., Patel, M., Adamis, A.P., Cunningham, E.T., Guyer, D.R., Katz, B., 2006. Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials. Ophthalmology 113, 992-1001.e6. DOI: 10.1016\/j.ophtha.2006.02.027.","DOI":"10.1016\/j.ophtha.2006.02.027"},{"key":"10.1016\/j.neuroscience.2025.09.027_b1155","doi-asserted-by":"crossref","first-page":"13713","DOI":"10.1038\/s41598-017-14175-5","article-title":"Posttranslational modifications of blood-derived alpha-synuclein as biochemical markers for Parkinson\u2019s disease","volume":"7","author":"Vicente Miranda","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151156","article-title":"Abnormal Salivary Total and Oligomeric Alpha-Synuclein in Parkinson\u2019s Disease","volume":"11","author":"Vivacqua","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neuroscience.2025.09.027_b1165","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.parkreldis.2019.02.014","article-title":"Salivary alpha-synuclein in the diagnosis of Parkinson\u2019s disease and Progressive Supranuclear Palsy","volume":"63","author":"Vivacqua","year":"2019","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1170","unstructured":"Wang, J., 2025. Detection of A-synuclein Aggregate as Biomarker in Diagnosing Parkinson's Disease at Early Stage by Using Protein Misfolding Cyclic Amplification (PMCA) (Clinical trial registration No. NCT04536857). clinicaltrials.gov."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1175","doi-asserted-by":"crossref","first-page":"512","DOI":"10.3390\/bioengineering9100512","article-title":"Recent advances in CRISPR\/Cas-based Biosensors for Protein Detection","volume":"9","author":"Wang","year":"2022","journal-title":"Bioengineering"},{"key":"10.1016\/j.neuroscience.2025.09.027_b1180","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000506480","article-title":"A Comparative Study of the Diagnostic potential of Plasma and Erythrocytic \u03b1-Synuclein in Parkinson\u2019s Disease","volume":"19","author":"Wang","year":"2020","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1185","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2020.112430","article-title":"CRISPR\/cas systems redefine nucleic acid detection: Principles and methods","volume":"165","author":"Wang","year":"2020","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1190","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.1002\/anie.201901292","article-title":"An RNA-Guided Cas9 Nickase-based Method for Universal Isothermal DNA Amplification","volume":"58","author":"Wang","year":"2019","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1195","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2023.117328","article-title":"Next-generation CRISPR-based diagnostic tools for human diseases","volume":"168","author":"Wang","year":"2023","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1200","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2022.339479","article-title":"Nicking enzyme-free strand displacement amplification-assisted CRISPR-Cas-based colorimetric detection of prostate-specific antigen in serum samples","volume":"1195","author":"Wang","year":"2022","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.neuroscience.2025.09.027_b1210","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s00604-014-1418-z","article-title":"Ultrasensitive and selective voltammetric aptasensor for dopamine based on a conducting polymer nanocomposite doped with graphene oxide","volume":"182","author":"Wang","year":"2015","journal-title":"Microchim. Acta"},{"key":"10.1016\/j.neuroscience.2025.09.027_b1215","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jad.2023.10.014","article-title":"The association of serum neurofilament light chains with early symptoms related to Parkinson\u2019s disease: a cross-sectional study","volume":"343","author":"Wang","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1220","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neulet.2015.05.030","article-title":"Detection of \u03b1-synuclein oligomers in red blood cells as a potential biomarker of Parkinson\u2019s disease","volume":"599","author":"Wang","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1225","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2023.131044","article-title":"The development of a fluorescence\/colorimetric biosensor based on the cleavage activity of CRISPR-Cas12a for the detection of non-nucleic acid targets","volume":"449","author":"Wang","year":"2023","journal-title":"J. Hazard. Mater."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1230","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ijbiomac.2019.05.176","article-title":"Facile preparation of a collagen-graphene oxide composite: a sensitive and robust electrochemical aptasensor for determining dopamine in biological samples","volume":"135","author":"Wei","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1235","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2022.114282","article-title":"Aptamer-based Cas14a1 biosensor for amplification-free live pathogenic detection","volume":"211","author":"Wei","year":"2022","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1240","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202214987","article-title":"CRISPR\u2010Cas Biochemistry and CRISPR\u2010Based Molecular Diagnostics","volume":"62","author":"Weng","year":"2023","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1245","doi-asserted-by":"crossref","unstructured":"Wroblewski, J.J., Wells, J.A., Adamis, A.P., Buggage, R.R., Cunningham, E.T., Goldbaum, M., Guyer, D.R., Katz, B., Altaweel, M.M., Pegaptanib in Central Retinal Vein Occlusion Study Group, 2009. Pegaptanib sodium for macular edema secondary to central retinal vein occlusion. Arch. Ophthalmol. Chic. Ill 1960 127, 374\u2013380. DOI: 10.1001\/archophthalmol.2009.14.","DOI":"10.1001\/archophthalmol.2009.14"},{"key":"10.1016\/j.neuroscience.2025.09.027_b1250","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2023.105939","article-title":"Estimating the sequence of biomarker changes in Parkinson\u2019s disease","volume":"118","author":"Xiang","year":"2024","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1255","unstructured":"Xiao, Y., 2025. Research on Novel Biomarkers for Early Diagnosis of Parkinson's Disease:An Observational, Multicenter, Non-Randomized Controlled Study (Clinical trial registration No. NCT06232772). clinicaltrials.gov."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1260","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1021\/jacs.9b09211","article-title":"Functional DNA Regulated CRISPR-Cas12a Sensors for Point-of-Care Diagnostics of Non-Nucleic Acid Targets","volume":"142","author":"Xiong","year":"2020","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1265","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3390\/brainsci14080787","article-title":"Alzheimer\u2019s Disease Related Biomarkers were Associated with Amnestic Cognitive Impairment in Parkinson\u2019s Disease: a Cross-Sectional Cohort Study","volume":"14","author":"Xue","year":"2024","journal-title":"Brain Sci."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1270","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1021\/jacs.2c12666","article-title":"Engineering a Ligase Binding DNA Aptamer into a Templating DNA Scaffold to Guide the Selective Synthesis of Circular DNAzymes and DNA Aptamers","volume":"145","author":"Yan","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1275","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41531-023-00572-3","article-title":"Neurofilament light chain as a mediator between LRRK2 mutation and dementia in Parkinson\u2019s disease","volume":"9","author":"Yang","year":"2023","journal-title":"NPJ Park. Dis."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1280","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1021\/jacs.4c08719","article-title":"CRISPR\/RNA Aptamer System Activated by an AND Logic Gate for Biomarker-Driven Theranostics","volume":"147","author":"Yang","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1285","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.135274","article-title":"Hemoglobin-\u03b1-synuclein complex exhibited age-dependent alterations in the human striatum and peripheral RBCs","volume":"736","author":"Yang","year":"2020","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1290","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1039\/D1SM00298H","article-title":"Simple, rapid and sensitive detection of Parkinson\u2019s disease related alpha-synuclein using a DNA aptamer assisted liquid crystal biosensor","volume":"17","author":"Yang","year":"2021","journal-title":"Soft Matter"},{"key":"10.1016\/j.neuroscience.2025.09.027_b1295","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.tins.2015.04.003","article-title":"Glial Fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker","volume":"38","author":"Yang","year":"2015","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1300","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1442173","article-title":"Plasma level of alpha-synuclein oligomers as a biomarker for isolated rapid eye movement sleep behavior disorder diagnosis and progression: a prospective cohort study","volume":"15","author":"Ying","year":"2024","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1305","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6526850","article-title":"High-Affinity Detection of Alpha-Synuclein by Aptamer-Gold Conjugates on an Amine-Modified Dielectric Surface","volume":"2019","author":"You","year":"2019","journal-title":"J. Anal. Methods Chem."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1310","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.1038\/s41598-023-32480-0","article-title":"Evaluation of plasma levels of NFL, GFAP, UCHL1 and tau as Parkinson\u2019s disease biomarkers using multiplexed single molecule counting","volume":"13","author":"Youssef","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1315","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.827493","article-title":"Erythrocytic \u03b1-Synuclein Species for Parkinson\u2019s Disease Diagnosis and the Correlations with Clinical Characteristics","volume":"14","author":"Yu","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1320","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2022.114424","article-title":"A novel \u201csignal on-off-super on\u201d sandwich-type aptamer sensor of CRISPR-Cas12a coupled voltage enrichment assay for VEGF detection","volume":"221","author":"Yuan","year":"2023","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1325","doi-asserted-by":"crossref","first-page":"17715","DOI":"10.1021\/acs.analchem.5c03015","article-title":"CRISPR\/Cas12a-Mediated Electrochemical Aptasensor for Simultaneous Determination of Alzheimer\u2019s Disease Biomarkers in Human Blood","volume":"97","author":"Yuan","year":"2025","journal-title":"Anal. Chem."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1330","doi-asserted-by":"crossref","first-page":"15254","DOI":"10.1021\/acs.analchem.3c02515","article-title":"Imaging Protein Aggregates in Parkinson\u2019s Disease Serum using Aptamer-Assisted Single-Molecule Pull-down","volume":"95","author":"Zhang","year":"2023","journal-title":"Anal. Chem."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1335","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.869797","article-title":"Lewy Body-Associated Proteins A-Synuclein (a-syn) as a Plasma-based Biomarker for Parkinson\u2019s Disease","volume":"14","author":"Zhao","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1340","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00216-019-02211-4","article-title":"Rapid and sensitive exosome detection with CRISPR\/Cas12a","volume":"412","author":"Zhao","year":"2020","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1345","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.omtn.2018.02.011","article-title":"Novel DNA Aptamers for Parkinson\u2019s Disease Treatment Inhibit \u03b1-Synuclein Aggregation and Facilitate its Degradation","volume":"11","author":"Zheng","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.neuroscience.2025.09.027_b1350","doi-asserted-by":"crossref","first-page":"52250","DOI":"10.1039\/C4RA08090D","article-title":"A simple label-free electrochemical aptasensor for dopamine detection","volume":"4","author":"Zhou","year":"2014","journal-title":"RSC Adv."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1355","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201903661","article-title":"CRISPR\/Cas13a Powered Portable Electrochemiluminescence Chip for Ultrasensitive and specific MiRNA Detection","volume":"7","author":"Zhou","year":"2020","journal-title":"Adv. Sci."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1360","doi-asserted-by":"crossref","first-page":"5012","DOI":"10.1038\/s41467-018-07324-5","article-title":"A CRISPR\u2013Cas9-triggered strand displacement amplification method for ultrasensitive DNA detection","volume":"9","author":"Zhou","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuroscience.2025.09.027_b1365","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.1074289","article-title":"Nucleic acid testing of SARS-CoV-2: a review of current methods, challenges, and prospects","volume":"13","author":"Zhu","year":"2022","journal-title":"Front. Microbiol."}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452225009510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452225009510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T08:40:06Z","timestamp":1780303206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452225009510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":271,"alternative-id":["S0306452225009510"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2025.09.027","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early detection of Parkinson\u2019s disease via aptamer-CRISPR platform","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2025.09.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Brain Research Organization (IBRO). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}